Stanford Medicine Children's Health Names New Chief of Pediatric Cardiology

Professor promoted to chief, bringing a legacy of mentorship and innovation

For release: July 1, 2022

Anne Dubin, MD, Professor of Pediatrics, has been appointed Chief of the Division of Pediatric Cardiology and Director of the Betty Irene Moore Children’s Heart Center at Lucile Packard Children’s Hospital Stanford. She will build upon the storied legacy of Stephen Roth, MD, MPH, in his 10 years as the distinguished leader of the Division and the Heart Center.

Dr. Dubin is widely recognized as an outstanding clinician, mentor, and educator, as well as an innovative clinical investigator for her impactful research on arrhythmias and cardiac resynchronization therapy in children with heart failure and congenital heart disease. She received her AB in Biochemistry at Mount Holyoke College and her MD from the University of Rochester. She completed her pediatrics residency at Columbia-Presbyterian Medical Center and her Pediatric Cardiology fellowship at Children’s Hospital of Philadelphia, followed by advanced clinical training in cardiac electrophysiology at Yale New Haven Hospital.

Dr. Dubin joined the faculty at Stanford in 1995. Since then, she has advanced all elements of our academic mission in leadership roles at Stanford Medicine and Lucile Packard Children’s Hospital Stanford. These include her service as a member of the Department of Pediatrics Committee on Appointments and Promotions, Director of Academic Affairs for the Division of Pediatric Cardiology, and the founding Director of the Pediatric Arrhythmia Service at Packard Children’s. Under her leadership, the comprehensive arrhythmia program emerged as a premier program in the United States, driving advances in resynchronization therapy in children, catheter-based arrhythmia ablation techniques, and the use of pacemakers and defibrillators in the smallest patients, including neonates and young infants.

Paramount to Dr. Dubin’s scholarly achievements is her innovative and collaborative approach. In a landmark paper, she demonstrated that resynchronization could be applied successfully in children. This set the standard in an emerging area of pediatric electrophysiology. She subsequently organized and led an international, multicenter study demonstrating the safety and efficacy of resynchronization therapy in children with congenital heart disease. Dr. Dubin has also been a leader in the dissemination of best practices in the field of pediatric arrhythmia diagnosis and treatment. She is a member of the Heart Rhythm Society Guidelines Committee and serves on the Pediatric and Congenital Electrophysiology Society/FDA Task Force for Development of Pediatric Devices. Within the Stanford School of Medicine and Department of Pediatrics, she has mentored dozens of medical students, residents, and fellows in successful clinical research projects, and she has also served as both an academic and career mentor to many early- and mid-career faculty in the Division of Pediatric Cardiology.